Abstract
Macroautophagy (hereafter, autophagy) is a process that directs the degradation of cytoplasmic material in lysosomes. In addition to its homeostatic roles, autophagy undergoes dynamic positive and negative regulation in response to multiple forms of cellular stress, thus enabling the survival of cells. However, the precise mechanisms of autophagy regulation are not fully understood. To identify potential negative regulators of autophagy, we performed a genome-wide CRISPR screen using the quantitative autophagic flux reporter GFP-LC3-RFP. We identified phosphoribosylformylglycinamidine synthase, a component of the de novo purine synthesis pathway, as one such negative regulator of autophagy. Autophagy was activated in cells lacking phosphoribosylformylglycinamidine synthase or phosphoribosyl pyrophosphate amidotransferase, another de novo purine synthesis enzyme, or treated with methotrexate when exogenous levels of purines were insufficient. Purine starvation-induced autophagy activation was concomitant with mammalian target of rapamycin complex 1 (mTORC1) suppression and was profoundly suppressed in cells deficient for tuberous sclerosis complex 2, which negatively regulates mTORC1 through inhibition of Ras homolog enriched in brain, suggesting that purines regulate autophagy through the tuberous sclerosis complex-Ras homolog enriched in brain-mTORC1 signaling axis. Moreover, depletion of the pyrimidine synthesis enzymes carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase and dihydroorotate dehydrogenase activated autophagy as well, although mTORC1 activity was not altered by pyrimidine shortage. These results suggest a different mechanism of autophagy induction between purine and pyrimidine starvation. These findings provide novel insights into the regulation of autophagy by nucleotides and possibly the role of autophagy in nucleotide metabolism, leading to further developing anticancer strategies involving nucleotide synthesis and autophagy.
Highlights
Responsible for the turnover of proteins and organelles and provides cells with an alternate source of nutrients for cellular renovation and homeostasis
Bulk knockout of pyrophosphate amidotransferase (PPAT) and methotrexate treatment both induced autophagy activation (Fig. 3D). These findings suggest that the activation of autophagy observed in phosphoribosylformylglycinamidine synthase (PFAS)-KO cells involves the impairment of the de novo purine synthesis pathway
These findings suggest that purine starvation induces autophagy primarily through the tuberous sclerosis complex (TSC)-Ras homolog enriched in brain (RHEB)-mammalian target of rapamycin complex 1 (mTORC1) signaling axis
Summary
Responsible for the turnover of proteins and organelles and provides cells with an alternate source of nutrients for cellular renovation and homeostasis. Our nonbiased screening identified the de novo purine synthesis enzyme phosphoribosylformylglycinamidine synthase (PFAS) as a negative regulator of autophagy. We performed a LentiCRISPRmediated bulk knockout of a human embryonic kidney (HEK) 293T cell line stably expressing GFP-LC3-RFP and Cas9 (HEK293T GFP-LC3-RFP cells) with a LentiCRISPR vector comprising single-guide RNAs (sgRNAs) targeting previously known negative regulators of autophagy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.